KARP NELSON M has a total of 34 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States, Russian Federation and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are JAPAN POLIOMYELITIS RES INST, ROCHE MADISON INC and TAIWAN MITOCHONDRION APPLIED TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | Russian Federation | 4 | |
#3 | Canada | 3 | |
#4 | Israel | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Australia | 2 | |
#7 | South Africa | 2 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Mexico | 1 | |
#10 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Agriculture | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Medical preparations | |
#5 | Climate change adaptation technologies | |
#6 | Animal care | |
#7 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Karp Nelson M | 32 |
Publication | Filing date | Title |
---|---|---|
US2011104196A1 | Immunogenic composition and method of developing a vaccine based on fusion protein | |
US2010275278A1 | Animal model for hiv induced disease | |
US2010086566A1 | Methods of inducing TH-1 immune responses to HIV-1 by administering UV/psoralen-treated desialated inactiviated HIV-1 virions deficient in CD55 and CD59 | |
US2008031872A1 | HIV immunogenic composition and method of administration | |
ZA200806722B | Animal model for HIV induced disease | |
CA2635722A1 | Animal model for hiv induced disease | |
US2008175836A1 | Immunogenic composition based on conditionally live virion and method for producing the same | |
US2006270960A1 | Treatment of blood with light | |
US2005112140A1 | Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide | |
AU2003238227A1 | Treatment of blood with light |